Clinical trials
Neoplasm Metastasis trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Recruiting | 3 |
| Not yet recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| British Columbia Cancer Agency | 9 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 5 |
| University Health Network, Toronto | 3 |
| American Medical Systems | 1 |
| Edwards Lifesciences | 1 |
| InSightec | 1 |
| John Street | 1 |
| Lady Davis Institute | 1 |
| Movember Foundation | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 28 |
| Neoplasms | 8 |
| Breast Neoplasms | 3 |
| Lung Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Recurrence | 2 |
| Body Weight | 1 |
| Bone Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Cancer Pain | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.